Suparna Visits 1 - 2: Cardiovascular Disease Risk Assessment and Management of a Woman with Metabolic Syndrome

Curriculum:
HDL MASTER CLASS MAY 2012
Credits:
1 ACPE 1 ANCC Contract Hours 1 CDR 1 AMA PRA Category 1 Credit(s)™
Launch Date:
19-Dec-12
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

Benjamin J. Ansell, MD, FNLA

Benjamin J. Ansell, MD, FNLA
Professor
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA

Benjamin J. Ansell, MD, received a dual undergraduate degree in biology and music from Cornell University and his Doctor of Medicine from the University of California Los Angeles (UCLA) School of Medicine, where he subsequently performed an internship and residency in Internal Medicine. Dr. Ansell currently serves as Professor of Medicine at the UCLA School of Medicine in the Divisions of General Internal Medicine and Cardiology. He also serves as Co-Director of the UCLA Cholesterol, Hypertension, & Atherosclerosis Management Program (CHAMP) and Director of the UCLA Cardiovascular Discovery Fund.

Dr. Ansell is a Fellow of both the American College of Physicians and the American College of Cardiology, a Board member of the National Lipid Association, a member of the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology, and a diplomate of both the American Board of Internal Medicine and the American Board of Clinical Lipidology. He is also past President of the Executive Board of the UCLA Department of Medicine. 
 
Chosen by US News and Town & Country magazines as one of the "Best Physicians in America," Dr. Ansell is also a prominent researcher of HDL and its relationship to vascular inflammation and heart disease. He has been principal investigator of the hs-CRP and HDL Effects of Statins Trial (CHEST), the Statins/HDL Increased Function Trial (SHIFT), and the Statin Anti-Rheumatic Activity (SARA) Trial. In addition, he authored or co-authored more than 50 scientific papers and book chapters. He has also been featured by The New York Times, CNN, ABC World News Tonight, 20/20, MSNBC, Dateline NBC, and National Public Radio. 
 
Dr. Ansell serves on the Board of Directors for Ashford Hospitality Trust (NYSE:AHT). He also is a member of the Board of Overseers for the Los Angeles Philharmonic Association. Previously from New York state and Colorado, Dr. Ansell has lived in Los Angeles for the last twenty-four years. He is married with three children.

Robert S. Rosenson, MD, FACC, FAHA, FACP, FNLA

Robert S. Rosenson, MD, FACC, FAHA, FACP, FNLA
Professor of Medicine
Mount Sinai School of Medicine
Director
Cardiometabolic Disorders
Mount Sinai Heart
New York, NY

Robert S. Rosenson, MD, is Professor of Medicine at the Mount Sinai School of Medicine where he serves as Director of Cardiometabolic Disorders.
 
Dr. Rosenson earned his medical degree from Tulane University in New Orleans, Louisiana. He then served his residency in medicine at Brigham and Women's Hospital in Boston, Massachusetts. He later completed a fellowship in cardiology at the University of Chicago that was followed by an additional year of training as a Research Associate in lipoprotein metabolism.
 
Dr. Rosenson has been involved in numerous grant-supported research investigations studying the effects of lipid-lowering therapy, hypoglycemic therapy, and antihypertensive agents in inflammation, thrombogenesis, and rheology. He has served as Principal Investigator on a number of NIH-funded research studies, pharmaceutical-sponsored drug trials, and multicenter studies. Recently, he served as Global Principal Investigator of the PLASMA I, PLASMA II and FRANCIS trials. He has been an invited speaker at more than 200 national and international association meetings, grand rounds, and symposia. He has authored nearly a total of 600 journal articles, book chapters, abstracts, and electronic publications for Up To Date Medicine. 
1. Describe the scope of residual risk in patients with cardiovascular disease.
2. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families